Ovagen 50mg Tablet contains Clomiphene citrate, a selective estrogen receptor modulator commonly used to induce ovulation in women experiencing anovulatory infertility. By blocking estrogen receptors in the hypothalamus, Clomiphene stimulates the release of gonadotropin-releasing hormone (GnRH), which in turn promotes the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary gland. This hormonal cascade facilitates follicular development and ovulation. Ovagen is indicated primarily for the treatment of ovulatory dysfunction in women desiring pregnancy, including those with polycystic ovary syndrome (PCOS). The recommended dosage is typically 50mg daily for five consecutive days, starting on the fifth day of the menstrual cycle, though dosage adjustments may be made based on clinical response. Common adverse effects include hot flashes, abdominal discomfort, nausea, and visual disturbances. Ovagen should be used cautiously in patients with liver disease, ovarian cysts, or uncontrolled thyroid or adrenal dysfunction. It is contraindicated in pregnancy, uncontrolled adrenal or thyroid disorders, and in patients with abnormal uterine bleeding of undetermined origin. Monitoring of ovarian response via ultrasound and serum hormone levels is advised to minimize the risk of ovarian hyperstimulation syndrome (OHSS). Ovagen should be prescribed and administered under the supervision of a qualified healthcare professional.